关于死亡率的真实世界COVID-19疫苗有效性研究中的数据和方法的演变:a 查看协议
Paulina Stehlik1,2, Caroline Dowsett3, Ximena Camacho4
1School of Pharmacy and Medical Sciences, Griffith University Faculty of Health, Gold Coast, Queensland, Australia p.stehlik@griffith.edu.au.
BMJ open
|March 20, 2024
概括
本范围审查审查考察了COVID-19疫苗有效性 (VE) 的现实世界研究 (RWS) 在大流行期间如何演变. 它确定了未来的流行病规划和政策所需的关键问题,数据和方法.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 随机试验提供了早期的COVID-19疫苗疗效数据.
- 真实世界研究 (RWS) 对于评估疫苗有效性 (VE) 和为全球疫苗接种政策提供信息至关重要.
- 对于 VE 的问题,数据,研究设计和分析方法在整个流行病期间都在发展.
研究的目的:
- 描述RWS在COVID-19疫苗有效性方面的演变.
- 为了确定在不同流行病阶段提出的问题类型.
- 确定必要的数据基础设施和方法,为未来的流行病做好准备.
主要方法:
- 对COVID-19 VE的RWS进行范围审查,包括死亡结果.
- 数据来源于约翰霍普金斯VIEW-hub数据库和其他主要科学存储库.
- 提取和专家审查研究特征,上下文,数据源和分析方法,使用时间线映射方法.
主要成果:
- 该审查将绘制RWS方法和数据利用在COVID-19大流行期间的演变图.
- 它将突出 VE 研究所涉及的研究问题不断变化的景观.
- 将提供关于快速 VE 评估所需的最小数据和分析基础设施的见解.
结论:
- 了解RWS的演变对于有效的流行病应对至关重要.
- 这一审查将为决策者提供有关未来公共卫生紧急情况的基本数据和方法要求的信息.
- 研究结果将有助于在随后的流行病中快速评估疫苗有效性和其他医疗保健策略.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:20Comparing the Survival Analysis of Two or More Groups
183
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
183
00:36Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
01:15Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126
01:25Statistical Methods for Analyzing Epidemiological Data
364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345